INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
43
SM
Sabag MarkSee "Remarks"
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Open-market sale
SELL$1.93M
46.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

Page 2 of 508
← PrevNext →
43
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Open-market sale
SELL
$8.75M
16.7K sh
Nov 4, 2026
Nov 6, 2026
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

43
OP
O'Hara Kevin PExecutive Vice President
HSTMHEALTHSTREAM INC
Open-market sale
SELL$124K
4,000 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

43
CM
Collier Michael ManningExecutive Vice President
HSTMHEALTHSTREAM INC
Open-market sale
SELL$101K
3,300 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

42
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.14M
1,215 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

41
CB
Crowl BenChief Lending Officer, EVP
FSBWFS Bancorp, Inc.
Open-market sale
SELL$236K
5,399 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

41
SK
Stillwell KennethCOO, CFO
PEGAPEGASYSTEMS INC
Open-market sale
SELL$578K
16.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

41
KO
Koren OferCFO
GLBEGlobal-E Online Ltd.
Open-market sale
SELL$550K
12.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$1.29M
3,978 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$2.97M
8,934 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$1.53M
3,612 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
FA
Fletcher Jeremy AdamEVP & CFO
ORLYO REILLY AUTOMOTIVE INC
Open-market sale
SELL$988K
10.6K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$1.41M
3,364 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$8.30M
25.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$8.86M
26.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$1.92M
5,870 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
TJ
Treff Douglas JDirector
CROXCrocs, Inc.
Open-market sale
SELL$1.71M
10.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
SJ
Schlosser Michael JEVP and Chief Clinical Officer
HCAHCA Healthcare, Inc.
Open-market sale
SELL$594K
1,200 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$4.96M
15.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.58M
10.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$2.11M
6,577 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.87M
11.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$3.87M
11.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$6.05M
18.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
BD
Bergwerk DovInterim Cheif Legal Officer
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Open-market sale
SELL$365K
8,755 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$2.38M
5,605 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

40
CA
Capuano AnthonyDirector, President & CEO
MARMARRIOTT INTERNATIONAL INC /MD/
Open-market sale
SELL$1.13M
2,710 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Open-market sale
SELL$3.76M
7,595 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

39
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$1.54M
3,120 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$4.77M
9,690 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$412K
439 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
HN
Hunn Laurence NeilDirector, President and CEO
ROPROPER TECHNOLOGIES INC
Open-market sale
SELL$2.16M
4,366 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Open-market sale
SELL$8.22M
15.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$541K
575 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$499K
529 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
SC
Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner
YOUClear Secure, Inc.
Open-market sale · 10b5-1 plan
SELL$10.00M
165.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
JL
Jordan Rhonda LDirector
ESABESAB Corp
Open-market sale
SELL$294K
3,733 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

39
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$925K
982 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

39
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Open-market sale
SELL$3.11M
6,302 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

37
Wilhelmsen Arne AlexanderDirector
RCLROYAL CARIBBEAN CRUISES LTD
Open-market sale
SELL$632K
1,974 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence